Masimo Corp (MASI)

171.02 +2.71 (+1.61%) USD  |  NASDAQ  |  Dec 26, 16:00
173.00 +1.98 (+1.16%) After-Hours: 06:53
More

Masimo Research and Development Expense (Quarterly): 48.30M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for MASI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 713.00M
AngioDynamics Inc 6.285M
Boston Scientific Corp 407.00M
Globus Medical Inc 35.38M
Tandem Diabetes Care Inc 51.11M